Menlo Park, CA · Founded 2017 · Privately Held (backing)
Developer of a genetic testing technology designed to provide comprehensive health insights through whole genome sequencing. MyOme is based in Menlo Park, CA and was founded in 2017. Its last reported valuation was $187 million in Dec 2025. It has raised $99.9 million.
Last reported valuation
$186.5M
Oct 2026
Priced at
—
Total raised
$99.9M
Last round
—
Cap table — not yet on record
MyOme's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of MyOme with a free account
·The complete investor list: 13 names
·Watch MyOme: the Monday email on marks, rounds and moves
